These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1493848)

  • 1. Pharmacokinetics and effects of atrial natriuretic factor during hypothermic cardiopulmonary bypass.
    Hynynen M; Olkkola KT; Palojoki R; Tikkanen I; Fyhrquist F
    Eur J Clin Pharmacol; 1992; 43(6):647-50. PubMed ID: 1493848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal and vascular effects of atrial natriuretic factor during cardiopulmonary bypass.
    Hynynen M; Palojoki R; Heinonen J; Tikkanen I; Harjula AL; Fyhrquist F
    Chest; 1991 Nov; 100(5):1203-9. PubMed ID: 1834440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of hypothermic cardiopulmonary bypass on atrial natriuretic factor levels.
    Kharasch ED; Yeo KT; Kenny MA; Amory DW
    Can J Anaesth; 1989 Sep; 36(5):545-53. PubMed ID: 2529049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure.
    Moe GW; Canepa-Anson R; Armstrong PW
    J Cardiovasc Pharmacol; 1992 May; 19(5):691-700. PubMed ID: 1381766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics, hemodynamic, renal, and neurohormonal effects of atrial natriuretic factor in experimental heart failure.
    Moe GW; Forster C; de Bold AJ; Armstrong PW
    Clin Invest Med; 1990 Jun; 13(3):111-8. PubMed ID: 2142031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of 125I-atrial natriuretic factor in anaesthetized rats. Effects of neutral endopeptidase inhibition with candoxatrilat and of ANF-C receptor blockade.
    Barclay PL; Bennett JA; Greengrass PM; Griffin A; Samuels GM; Shepperson NB
    Biochem Pharmacol; 1992 Sep; 44(6):1013-22. PubMed ID: 1417928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of incremental infusions of atrial natriuretic factor on aldosterone, renin, and blood pressure in humans.
    Oelkers W; Kleiner S; Bähr V
    Hypertension; 1988 Oct; 12(4):462-7. PubMed ID: 2971619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects and pharmacokinetics of bolus injections of atrial natriuretic factor in normal volunteers.
    Cusson JR; Du Souich P; Hamet P; Schiffrin EL; Kuchel O; Tremblay J; Cantin M; Genest J; Larochelle P
    J Cardiovasc Pharmacol; 1988 Jun; 11(6):635-42. PubMed ID: 2457757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of doxacurium during normothermic and hypothermic cardiopulmonary bypass surgery.
    Asokumar B; Cheng D; Chung F; Peniston C; Sandler A; Varin F
    Can J Anaesth; 1998 Jun; 45(6):515-20. PubMed ID: 9669003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial natriuretic factor in normothermic and hypothermic cardiopulmonary bypass.
    Brancaccio G; Michielon G; Di Donato RM; Costa D; Falzea F; Miraldi F
    Perfusion; 2004 May; 19(3):157-62. PubMed ID: 15298423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic cardiovascular responses to infusions of atrial natriuretic factor in humans.
    Ebert TJ; Skelton MM; Cowley AW
    Hypertension; 1988 Jun; 11(6 Pt 1):537-44. PubMed ID: 2968309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
    Kukkonen P; Vuolteenaho O; Ruskoaho H
    Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity Does Not Affect Propofol Pharmacokinetics During Hypothermic Cardiopulmonary Bypass.
    El-Baraky IA; Abbassi MM; Marei TA; Sabry NA
    J Cardiothorac Vasc Anesth; 2016 Aug; 30(4):876-83. PubMed ID: 27236490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal and endocrine effects of physiological variations of atrial natriuretic factor in normal humans.
    Bruun NE; Skøtt P; Giese J
    Am J Physiol; 1991 Jan; 260(1 Pt 2):R217-24. PubMed ID: 1847023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasodilator properties of atrial natriuretic factor: a comparison with nitroglycerin, nitroprusside, and phentolamine during cardiopulmonary bypass.
    Hynynen M; Palojoki R; Salmenperä M; Tikkanen I; Harjula A; Fyhrquist F; Heinonen J
    J Cardiothorac Anesth; 1989 Dec; 3(6):720-5. PubMed ID: 2535309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal dose response and pharmacokinetics of atrial natriuretic factor in dogs.
    Cernacek P; Maher E; Crawhall JC; Levy M
    Am J Physiol; 1988 Dec; 255(6 Pt 2):R929-35. PubMed ID: 2974253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced natriuretic effect of atrial natriuretic factor during mineralocorticoid escape in humans.
    Gaillard CA; Koomans HA; Rabelink TJ; Braam B; Boer P; Dorhout Mees EJ
    Hypertension; 1988 Oct; 12(4):450-6. PubMed ID: 2971618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance function of type C receptors of atrial natriuretic factor in rats.
    Almeida FA; Suzuki M; Scarborough RM; Lewicki JA; Maack T
    Am J Physiol; 1989 Feb; 256(2 Pt 2):R469-75. PubMed ID: 2537040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone and renin inhibition by physiological levels of atrial natriuretic factor.
    Brands MW; Freeman RH
    Am J Physiol; 1988 Jun; 254(6 Pt 2):R1011-6. PubMed ID: 2968054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natriuretic and diuretic effects of infusion of atrial natriuretic factor in conscious dogs.
    Ohanian J; Young MA; Shen YT; Gaivin R; Vatner SF; Graham RM
    Am J Physiol; 1989 Oct; 257(4 Pt 2):F565-73. PubMed ID: 2529778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.